:quality(75)/cdn.jwplayer.com/v2/media/5h1UIiRn/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yaeAEDyq/poster.jpg)
Brasil aprueba uso de vacunas contra COVID-19 de china Sinovac y de AstraZeneca
La Agencia Nacional de Vigilancia Sanitaria (Anvisa) de Brasil aprobó el domingo por unanimidad el uso de emergencia de la vacuna CoronaVac del laboratorio chino Sinovac contra la enfermedad del nuevo coronavirus (COVID-19), así como de la farmacéutica AstraZeneca-Universidad de Oxford. Fuente: [Xinhua]
MÁS RECIENTES
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/XLIWX6IVYFA63APPYFLFMQREXI.jpg)
Pueblo Libre: clausuran chifa que almacenaba pollo en bolsas y reutilizaba aceite para frituras
:quality(75)/cdn.jwplayer.com/v2/media/frIfgMIX/poster.jpg)
Janet sobre supuesto bebé que esperan Samahara y Bryan: “Una irresponsabilidad, ellos no son estables”
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/OEOX64ECKFBR5H3UAOANUZ3Q2E.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/s0C6EY3S/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Fp4txKkv/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/0Iveihj3/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/WJ7ovIRU/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/XLIWX6IVYFA63APPYFLFMQREXI.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/OEOX64ECKFBR5H3UAOANUZ3Q2E.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/t8AjJvjZ/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FACEUXZLE5DNHFQEAYVP66PHSI.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/frIfgMIX/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/5h1UIiRn/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/pWNnuH5w/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/zDickTFG/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/cAs1Uyyl/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/TVKBQS3TEJATNJ2O5DPSM6WRRQ.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/V2ABWUUBNNAEZJ4FSI64SU5O3U.png)
:quality(75)/cdn.jwplayer.com/v2/media/KBOpcpUE/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/koNs9MA2/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6bLTGi5d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/KgeU8b6Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/a6mwPQ4X/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X3PAJUVAAFHRXHUYV5TON7UAAY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/wXUo9jVU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/nu9nKgwG/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GCHGHNUMHVAIDBFA2VHOVRIAMY.png)
:quality(75)/cdn.jwplayer.com/v2/media/c0S03whF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/azLadx4o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5XSTUGQ5DI3DYDC3MUSLQL6A.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9a1H4G0a/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Xv8iJGpA/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/EXTCEP2GUBC7XBDWQE34RG4BO4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/DOIUFLVUQ5AJDN2ZVTQQC7KHZ4.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/dXst1BW1/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JW2JBE7IBZEY5NR2VH4KVTPGZ4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/42WZKDIDGVA6VKQDF75376W2CA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ENCJ6JEIFZHT5E6UXK3KZ5RCUU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ27WLDNBFBCPCMLG42DQCNJYA.png)